参考文献/References:
[1] 中国垂体腺瘤协作组. 中国垂体催乳素腺瘤诊治共识（2014版）[J]. 中华医学杂志，2014，94（31）：2406-2411.
[2] Trouillas J, Delgrange E, Jouanneau E, et al. Prolactinoma in man: clinical and histological characteristics [J]. Ann Endocrinol, 2000, 61(5): 253-257.
[3] Pinzone JJ, Katznelson L, Dani la DC, et al. Primary medicaltherapy of micro and macro prolactinomas in men [J]. J Clin Endocrinol Metab, 2000, 85(9): 3053-3057.
[4] 惠国桢，王清，李向东，等. 经蝶窦显微手术治疗男性泌乳素腺瘤的长期随访分析[J]. 中华神经外科杂志，2005，21：535-538.
[5] Salazar-López-Ortiz CG, Herndández-Bueno JA, Gonzá1ez Bárcena-D. et al. Clinical practice guideline for the diag-nosis and treatment of hyperprolactinemia [J]. Ginecol Obstet Mex, 2014, 82(2): 123-142.
[6] 朱明欣，张华楸，刘胜文，等. 手术治疗男性垂体泌乳素腺瘤73例临床分析[J]. 中国微侵袭神经外科杂志，2012，17（8）：359-361.
[7] Delgrange E, Vasiljevic A, Wierinckx A, et al. Expression of estrogen receptor alpha is associated with pmlactin pituitarytumor prognosis and supports the sex-related difference in tumor growth [J]. Eur J Endocrinol, 2015, 172(6): 791-801.
[8] Colao A, Vitale G, Cappabianca P, et al. Outcome of caber-gol ine treatment in men with prolactinoma: effects of a 24 month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis [J]. J Clin Endo-crinol Metab, 2004, 89(4): 1704-1711.
[9] Wong A, Eloy JA, Couldwell WT, et al. Update on prolacti-nomas. Part 2: Treatment and management strategies [J]. J Clin Neurosci, 2015, 22(10): 1568-1574.
[10] Mete O, Ezzat S, Asa SL. Biomarkers of aggressive pituitary adenomas [J]. J Mol Endocrinol, 2012, 49(2): R69-R78.
[11] 陈美婷，连 伟，幸 兵，等. 男性垂体泌乳素腺瘤手术疗效预测因子的分析[J]. 中国医学科学院学报，2016，38（4）：383-387.
[12] Losa M, Mortini P, Barzaghi R, et al. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long. term outcome [J]. J Clin Endocrinol Metab, 2002, 87(7): 3180-3186.
[13] Roux FX, Nataf F, Page P, et al. The role of surgery in the treavment of prolactinoma [J]. Cynecol Obstet Fertil, 2002, 30(5): 367-373.
[14] Tortosa F, Webb SM. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal [J]. Neurolo-gia, 2016, 31(2): 97-105.
相似文献/References:
[1]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[2]王国良 高 寒 张小鹏 公方和 李天栋.89例垂体腺瘤的手术治疗体会[J].中国临床神经外科杂志,2016,(07):435.[doi:10.13798/j.issn.1009-153X.2016.07.016]
[3]王亚平 贾晓雄 王 珺 王林林 谭溢涛 马德得 夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(12):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[4]张海红 马 磊 张 威 郭 康 衡立君 贾 栋.垂体腺瘤MRI特征与视觉功能损害的关系分析[J].中国临床神经外科杂志,2016,(01):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
ZHANG Hai-hong,MA Lei,ZHANG Wei,et al.Analysis of MRI characteristics and visual function in patient with pituitary adenomas[J].,2016,(12):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
[5]王先祥 张义泉 李庆新 王 斌 肖 瑾 张 科.经单鼻孔蝶窦入路神经内镜下切除垂体腺瘤[J].中国临床神经外科杂志,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
WANG Xian-xiang,ZHANG Yi-quan,LI Qing-xin,et al.Endoscopic endonasal transsphenoidal surgery for pituitary adenomas[J].,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
[6]马 涛 徐 韬.经蝶入路内镜手术与显微手术治疗垂体腺瘤疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):748.[doi:10.13798/j.issn.1009-153X.2015.12.015]
[7]雷 霆.注重基础训练和知识更新，不断提高垂体腺瘤诊疗水平[J].中国临床神经外科杂志,2015,(10):577.[doi:10.13798/j.issn.1009-153X.2015.10.001]
[8]闫 进 李 松 杨 辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(12):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[9]夏为民 邵耐远 唐 科.神经内镜辅助经鼻蝶入路手术治疗急性垂体腺瘤卒中[J].中国临床神经外科杂志,2015,(07):437.[doi:10.13798/j.issn.1009-153X.2015.07.020]
[10]王齐齐 陈 俊 王焕明 胡 飞.脊索瘤合并垂体腺瘤1例[J].中国临床神经外科杂志,2015,(07):448.[doi:10.13798/j.issn.1009-153X.2015.07.025]
[11]淦 超 李朝曦 陈 娟 徐 钰 张华楸 雷 霆.女性泌乳素腺瘤手术预后的影响因素分析[J].中国临床神经外科杂志,2017,(06):395.[doi:10.13798/j.issn.1009-153X.2017.06.009]
GAN Chao,LI Chao-xi,CHEN Juan,et al.Risk factors for prognosis of female prolactinoma patients after transphenoidal surgery[J].,2017,(12):395.[doi:10.13798/j.issn.1009-153X.2017.06.009]